Autobio Diagnostics Co., Ltd. (SHA:603658)
33.56
-0.61 (-1.79%)
Aug 4, 2026, 3:00 PM CST
Autobio Diagnostics Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,223 | 4,226 | 4,471 | 4,444 | 4,442 | 3,766 |
Revenue Growth | -3.55% | -5.47% | 0.62% | 0.05% | 17.94% | 26.45% |
Gross Profit Gross Profit Growth | 2,737 | 2,724 | 2,889 | 2,832 | 2,597 | 2,221 |
Operating Income Operating Income Growth | 1,029 | 1,062 | 1,152 | 1,206 | 1,126 | 954.28 |
Net Income Net Income Growth | 1,035 | 1,068 | 1,194 | 1,217 | 1,167 | 973.66 |
Earnings Per Share EPS Growth | 1.81 | 1.87 | 2.07 | 2.10 | 2.00 | 1.66 |
EPS Growth | -8.61% | -9.66% | -1.43% | 5.00% | 20.48% | 23.88% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 3,757 |
Overseas Overseas Growth | 383.78 |
Total Total Growth | 4,141 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 983.59 | 4,052 | 4,043 | 4,521 | 4,278 | 3,777 |
Total Debt Total Debt Growth | 68.69 | 54.88 | 554.19 | 730.85 | 142.66 | 257.4 |
Net Cash (Debt) Net Cash Growth | 914.9 | 3,997 | 3,488 | 3,790 | 4,136 | 3,520 |
Net Cash Growth | 718.61% | 14.58% | -7.95% | -8.37% | 17.50% | 6.70% |
Net Cash Per Share Net Cash Per Share Growth | 1.60 | 7.00 | 6.05 | 6.54 | 7.08 | 6.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,322 | 1,342 | 1,309 | 1,470 | 1,558 | 1,461 |
Capital Expenditures CapEx Growth | -590.67 | -604.3 | -664.4 | -900.42 | -938.32 | -1,066 |
Free Cash Flow Free Cash Flow Growth | 731.25 | 737.38 | 644.88 | 569.44 | 620.1 | 395.39 |
Free Cash Flow Growth | 28.95% | 14.34% | 13.25% | -8.17% | 56.83% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.82% | 64.45% | 64.61% | 63.73% | 58.47% | 58.98% |
Operating Margin | 24.36% | 25.13% | 25.77% | 27.15% | 25.36% | 25.34% |
Pretax Margin | 28.01% | 28.93% | 28.83% | 30.66% | 29.13% | 28.29% |
Profit Margin | 24.50% | 25.27% | 26.71% | 27.40% | 26.28% | 25.86% |
FCF Margin | 17.32% | 17.45% | 14.42% | 12.81% | 13.96% | 10.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.310 | 1.310 | 1.260 | 1.052 | 0.800 | 0.750 |
Dividend Per Share Growth | 3.97% | 3.97% | 19.76% | 31.51% | 6.67% | 14.71% |
Dividend Yield | 3.96% | 3.85% | 3.10% | 2.03% | 1.44% | 1.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.88 | 18.95 | 20.90 | 27.21 | 31.06 | 33.15 |
Forward PE | 17.15 | 16.00 | 16.30 | 24.79 | 28.63 | 31.67 |
P/FCF Ratio | 26.70 | 27.45 | 38.72 | 58.17 | 58.48 | 81.64 |
PS Ratio | 4.62 | 4.79 | 5.58 | 7.45 | 8.16 | 8.57 |